CK Life Sciences International (Holdings), Inc. (775) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd.

Zhongzhi Pharmaceutical Holdings Ltd.

China Shineway Pharmaceutical Group Ltd.

Shandong Xinhua Pharmaceutical Co., Ltd.

Sihuan Pharmaceutical Holdings Group Ltd.

HBM Holdings Ltd.

CK Life Sciences International (Holdings), Inc.

Wai Yuen Tong Medicine Holdings Ltd.

PuraPharm Corp. Ltd.

Hin Sang Group (International) Holding Co. Ltd.

China Health Group, Inc.

Why is CK Life Sciences International (Holdings), Inc. ?

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0.51%

The company is Net-Debt Free

Flat results in Dec 25

OPERATING CASH FLOW(Y) Lowest at HKD 24.84 MM
RAW MATERIAL COST(Y) Grown by 28.66% (YoY)
DEBT-EQUITY RATIO (HY) Highest at 159.23 %

With ROE of 1.27%, it has a Very Expensive valuation with a 2.10 Price to Book Value

Over the past year, while the stock has generated a return of -17.44%, its profits have fallen by -60.1%

Below par performance in long term as well as near term

Along with generating -17.44% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is CK Life Sciences International (Holdings), Inc. for you?

Medium Risk, High Return

Absolute

Risk Adjusted

Volatility

CK Life Sciences International (Holdings), Inc.

-17.44%

2.63

35.98%

Hang Seng Hong Kong

8.76%

0.45

19.63%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

381.57%

EBIT Growth (5y)

69.38%

EBIT to Interest (avg)

0.24

Debt to EBITDA (avg)

2.62

Net Debt to Equity (avg)

1.42

Sales to Capital Employed (avg)

0.27

Tax Ratio

100.00%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

0.51%

ROE (avg)

1.31%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

165

Industry P/E

Price to Book Value

2.10

EV to EBIT

992.72

EV to EBITDA

148.39

EV to Capital Employed

1.46

EV to Sales

4.96

PEG Ratio

Dividend Yield

ROCE (Latest)

0.15%

ROE (Latest)

1.27%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

PRE-TAX PROFIT(Q)

Highest at HKD 116.21 MM

NET PROFIT(Q)

At HKD -35.73 MM has Grown at 72.92%

-8What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at HKD 24.84 MM

RAW MATERIAL COST(Y)

Grown by 28.66% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 159.23 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.15 times

OPERATING PROFIT(Q)

Lowest at HKD -54.48 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -1.94 %

Here's what is working for CK Life Sciences International (Holdings), Inc.

Pre-Tax Profit

At HKD 116.21 MM has Grown at 215.25%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (HKD MM)

Pre-Tax Profit

Highest at HKD 116.21 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Net Profit

At HKD -35.73 MM has Grown at 72.92%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (HKD MM)

Here's what is not working for CK Life Sciences International (Holdings), Inc.

Operating Cash Flow

Lowest at HKD 24.84 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)

Operating Profit

Lowest at HKD -54.48 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (HKD MM)

Operating Profit Margin

Lowest at -1.94 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Debt-Equity Ratio

Highest at 159.23 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 5.15 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 28.66% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales